08:00 , Dec 24, 2007 |  BC Week In Review  |  Clinical News

Oradel insulin: Phase I start

In mid-2008, AOP will begin a Phase I trial in healthy volunteers. Apollo Life Sciences Ltd. (ASX:AOP), Beaconsfield, Australia   Product: Oradel insulin   Business: Endocrine   Molecular target: Insulin receptor   Description: Insulin loaded...
08:00 , Feb 5, 2007 |  BC Week In Review  |  Clinical News

Apollo Life Sciences Ltd. preclinical data

Data from rats and rabbits showed that Oradel oral insulin was safe. There were no mortalities or toxic effects at both the low and high doses of insulin loaded with Oradel oral delivery technology. Also,...
08:00 , Jan 30, 2006 |  BC Week In Review  |  Clinical News

Topical psoriasis cream: Preliminary Phase Ib data

Preliminary data from a 3-stage, Australian Phase Ib trial in 20 healthy volunteers and patients with mild to moderate chronic plaque type psoriasis showed that topical ALS-00T2-0501 cream was safe and well tolerated. In the...
07:00 , Oct 24, 2005 |  BC Week In Review  |  Clinical News

Topical psoriasis cream: Phase Ib started

AOP started an Australian Phase Ib trial in healthy volunteers. Apollo Life Sciences Ltd. (ASX:AOP), Beaconsfield, Australia   Product: Topical psoriasis cream   Business: Autoimmune   Molecular target: NA   Description: Tumor necrosis factor (TNF)...